BMY BRISTOL-MYERS SQUIBB CO
2026Q1 · CUSIP 110122108 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
2,512
Δ holders QoQ
+63
Breadth percentile
Top 3%
Whale holders
341
Δ whales
+1
Inst. holding value
$91.8B
New positions
267
Closed positions
204
Price momentum (1Q)
-4.1%
Put / Call
49/55
Breadth history (34 quarters)
Past Lit Events & Aftermath 17 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 3% | — | — |
| 2025Q4 | Top 1% | -4.1% | — |
| 2024Q4 | Top 1% | -12.3% | -9.0% |
| 2024Q3 | Top 1% | -0.6% | -15.4% |
| 2022Q4 | Top 1% | -6.5% | -10.9% |
| 2022Q2 | Top 5% | +3.8% | -2.1% |
| 2022Q1 | Top 1% | -4.0% | -1.1% |
| 2021Q4 | Top 2% | +14.8% | +11.3% |
Options Sentiment
Put holders
49
QoQ: +4
Call holders
55
QoQ: +14
See methodology →
Fundamentals
PE (TTM)
17.0
EPS (TTM)
$3.57
EPS YoY
+33.2%
Revenue (TTM)
$48.5B
Revenue YoY
+1.8%
Net margin
15.0%
ROE
36.3%
Debt ratio
76.8%
FCF (TTM)
$11.9B
Dividend (TTM)
$2.50
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.